cat
continu
becom
popular
household
companion
pet
varieti
viral
infect
pose
seriou
threat
felin
includ
high
incid
felin
leukemia
viru
felv
felin
coronaviru
fcov
felin
immunodefici
viru
fiv
felin
panleukopenia
viru
fpv
current
prevent
vaccin
therapeut
drug
avail
use
pet
cat
limit
effect
nevertheless
interferon
ifn
play
increasingli
complementari
role
antivir
therapi
virusinfect
cat
main
function
ifn
antivir
immun
respons
induc
express
antivir
protein
activ
antivir
antiprolif
immunomodulatori
cellular
respons
gener
ifn
classifi
three
subgroup
type
ifn
type
ii
ifn
type
iii
ifn
type
ifn
includ
play
direct
role
antivir
immun
respons
type
ii
ifn
name
produc
lymphocyt
natur
killer
cell
respons
recognit
infect
cell
type
iii
ifn
includ
regul
antivir
immun
respons
via
distinct
receptor
complex
similar
type
ifn
interferon
omega
produc
primarili
leukocyt
display
similar
structur
physicochem
characterist
type
ifn
research
focus
develop
therapeut
drug
base
felin
treat
viral
infect
cat
felv
import
pathogen
domest
wild
cat
caus
degen
immunosuppress
disord
anorexia
apathi
cachexia
progress
weak
publish
research
demonstr
therapeut
potenti
treat
felvinfect
cat
presum
inhibit
replic
cycl
felv
sever
studi
reveal
recombin
felin
statist
signific
therapeut
effect
felv
infect
felvfiv
coinfect
current
serv
immunomodul
first
interferon
licens
use
cat
treat
felv
fiv
canin
parvoviru
infect
felin
infecti
periton
trigger
felin
infecti
periton
viru
fipv
virul
mutant
felin
enter
coronaviru
lethal
infecti
diseas
cat
still
effect
drug
avail
treatment
previou
studi
demonstr
repres
therapeut
candid
treat
fipvinfect
cat
addit
data
sever
studi
suggest
also
exert
protect
effect
viral
infect
includ
bovin
enteroviru
bev
infecti
bovin
rhinotrach
viru
bovin
viral
diarrhea
viru
bvdv
vesicular
stomat
viru
vsv
pseudorabi
viru
prv
felin
parvoviru
felin
caliciviru
felin
coronaviru
studi
two
novel
gene
encod
call
clone
spleen
lymphocyt
cat
stimul
vsv
infect
combin
poli
c
treatment
gene
express
solubl
form
escherichia
coli
molecular
characterist
analyz
speciesspecif
broadspectrum
antivir
activ
evalu
vitro
result
suggest
protein
describ
studi
show
promis
potenti
serv
effect
therapeut
agent
felin
viral
infect
plasmid
simpl
prokaryot
solubl
express
plasmid
pcoldtf
use
studi
african
green
monkey
kidney
vero
cell
atcc
bovin
kidney
mdbk
cell
porcin
kidney
cell
canin
kidney
mdck
cell
felin
kidney
cell
kept
laboratori
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
ny
usa
supplement
fetal
bovin
serum
fb
gibco
ny
usa
felin
coronaviru
fcov
propag
cell
porcin
epidem
diarrhea
viru
pedv
propag
vero
cell
vsv
propag
vero
cell
bovin
viral
diarrhea
viru
bvdv
propag
mdbk
cell
canin
parvoviru
cpv
propag
mdck
cell
healthi
dragon
li
cat
n
purchas
pet
market
harbin
china
anim
experi
carri
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
ethic
committe
anim
experi
northeast
agricultur
univers
harbin
china
juli
confluent
monolay
cell
infect
vsv
moi
h
remov
inoculum
cell
wash
maintain
dmem
supplement
fb
gibco
grand
island
ny
usa
cytopath
effect
cpe
observ
exceed
perform
supernat
harvest
store
requir
cat
intramuscularli
inject
daili
ml
vsv
combin
mgml
poli
c
three
consecut
day
day
postinfect
cat
euthan
splenic
lymphocyt
isol
asept
use
total
rna
extract
trizol
total
rna
isol
kit
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
subsequ
firststrand
cdna
revers
transcrib
use
quantitect
revers
transcript
kit
qiagen
hilden
germani
accord
manufactur
instruct
gene
encod
felin
obtain
pcr
amplif
degener
primer
pair
f
contain
kpn
restrict
site
r
contain
bamh
restrict
site
design
accord
gene
sequenc
known
publish
genbank
access
number
gene
subclon
simpl
plasmid
subject
sequenc
bioinformat
analys
homolog
phylogenet
tree
analysi
felin
gene
isol
studi
analyz
use
dnastar
softwar
addit
characterist
gene
protein
analyz
sever
onlin
bioinformat
softwar
program
signal
peptid
cleavag
site
analyz
signalp
server
http
phosphoryl
site
analyz
server
http
wwwcbsdtudkservicesnetpho
nglycosyl
site
analyz
server
http
wwwcbsdtudkservicesnetnglyc
oglycosyl
site
analyz
server
http
wwwcbsdtudkservicesyinoyang
subcellular
local
analyz
targetp
server
http
wwwcbsdtudkservicestargetp
transmembran
region
analyz
tmhmm
server
http
wwwcbsdtudkservicestmhmm
antigen
epitop
hydrophob
analyz
bepipr
server
http
secondari
threedimension
structur
predict
sopma
http
npsaprabiibcpfrcgibinnpsa
studi
gene
encod
isol
rtpcr
subclon
kpni
bamhigener
new
england
biolab
usa
gene
fragment
prokaryot
solubl
express
plasmid
pcoldtf
give
rise
recombin
recombin
plasmid
transform
e
coli
compet
cell
valid
pcr
sequenc
analys
thu
gener
recombin
e
coli
strain
use
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
analysi
determin
optim
condit
express
recombin
cell
via
induct
isopropyl
iptg
sigma
st
loui
mo
usa
briefli
optim
iptg
concentr
recombin
e
coli
strain
grown
broth
sigma
st
loui
mo
usa
supplement
ampicillin
optic
densiti
nm
approxim
iptg
ad
final
concentr
mmoll
mmoll
mmoll
mmoll
mmoll
cultur
continu
cultiv
anoth
h
centrifug
g
min
cell
pellet
lyse
analyz
sdspage
determin
optim
induct
time
recombin
strain
induc
optim
final
concentr
iptg
h
h
h
h
h
follow
centrifug
cell
lysi
protein
analyz
sdspage
fusion
protein
express
bacteria
cell
subject
cleavag
proteas
sigma
st
loui
mo
usa
target
recombin
protein
purifi
use
affin
chromatographi
column
accord
manufactur
instruct
follow
confirm
analysi
use
sdspage
purifi
protein
store
use
vsv
use
viru
model
evalu
antivir
activ
recombin
via
vitro
microdos
cytopath
effect
inhibit
assay
mcia
accord
method
describ
previous
slight
modif
briefli
purifi
sampl
serial
dilut
tenfold
dmem
contain
fb
transfer
confluent
cell
monolay
cell
cultur
plate
incub
h
cell
without
ifn
treatment
use
control
group
incub
vsv
moi
prepar
describ
ad
plate
incub
h
cpe
cell
viral
control
group
reach
next
cultur
medium
remov
cell
stain
crystal
violet
ethanol
min
cell
destain
acet
acid
ethanol
min
determin
absorb
well
nm
sampl
perform
eight
biolog
replic
three
technic
replic
antivir
activ
ifn
calcul
method
previous
describ
express
unit
per
milligram
accord
ratio
ifn
titer
protein
concentr
parallel
intercat
ifn
antivir
drug
toray
industri
tokyo
japan
use
ifn
treatment
control
addit
determin
speciesspecif
antivir
activ
recombin
conduct
mcia
use
vsv
vero
mdck
mdbk
cell
broadspectrum
antivir
activ
recombin
determin
conduct
mcia
use
vsv
fcov
cpv
bvdv
pedv
result
shown
mean
sem
n
three
independ
experi
statist
analys
perform
use
graphpad
prism
softwar
tukey
multipl
comparison
test
oneway
analysi
varianc
anova
test
use
analyz
signific
differ
group
p
p
p
first
collect
splenic
lymphocyt
cat
infect
vsv
treat
poli
c
simultan
perform
rtpcr
assay
use
pair
degener
primer
identifi
two
gene
encod
refer
figur
two
novel
gene
deposit
genbank
access
number
follow
nucleotid
sequenc
homolog
analysi
found
gene
size
bp
share
maximum
nucleotid
sequenc
homolog
amino
acid
homolog
known
subtyp
gene
publish
genbank
figur
gene
size
bp
share
maximum
sequenc
homolog
amino
acid
homolog
known
subtyp
figur
sequenc
homolog
share
gene
figur
indic
two
gene
identifi
studi
novel
gene
construct
phylogenet
tree
compar
gene
identifi
studi
ifn
gene
sequenc
publish
genbank
differ
anim
use
softwar
dnastar
megalign
result
show
gene
belong
type
ifn
famili
evolutionari
relationship
known
felin
gene
alreadi
publish
genbank
figur
distant
indic
gene
identifi
first
time
new
subtyp
felin
characterist
novel
felin
protein
analyz
use
sever
onlin
bioinformat
softwar
program
includ
identif
potenti
signal
peptid
cleavag
site
nglycosyl
site
oglycosyl
site
phosphoryl
site
subcellular
local
transmembran
region
result
detail
analys
display
tabl
addit
also
use
onlin
softwar
algorithm
predict
antigen
epitop
hydrophob
secondari
threedimension
structur
protein
shown
figur
antigen
epitop
predict
bepipr
softwar
locat
amino
acid
residu
figur
antigen
epitop
locat
amino
acid
residu
figur
maximum
hydrophob
minimum
hydrophob
maximum
hydrophob
minimum
hydrophob
secondari
structur
two
protein
predict
use
sopma
softwar
reveal
contain
alpha
helix
beta
sheet
irregular
curl
structur
figur
wherea
contain
alpha
helix
beta
sheet
irregular
curl
structur
figur
threedimension
structur
predict
swissmodel
softwar
shown
figur
f
respect
gene
encod
subclon
prokaryot
solubl
express
vector
pcoldtf
transform
e
coli
compet
cell
thu
gener
recombin
protein
express
e
coli
strain
induc
express
iptg
figur
figur
protein
fuse
trigger
factor
tf
approxim
kda
primarili
express
solubl
form
subsequ
optim
express
condit
protein
e
coli
strain
observ
indic
optim
induct
condit
protein
express
iptg
concentr
mmoll
figur
induct
time
h
figur
optim
induct
condit
protein
express
iptg
concentr
mmoll
figur
induct
time
h
figur
fuse
protein
purifi
histag
affin
column
chromatographi
subject
cleavag
use
proteas
cleav
protein
purifi
histag
affin
column
chromatographi
collect
purifi
recombin
protein
molecular
weight
approxim
kda
kda
respect
figur
determin
antivir
activ
use
microdos
cytopath
effect
inhibit
assay
mcia
vsv
viral
model
propag
cell
shown
figur
demonstr
good
antivir
activ
similar
intercat
ifn
felin
ifn
antivir
drug
posit
control
howev
antivir
effect
neg
control
group
cell
untreat
ifn
detect
test
whether
antivir
activ
speciesspecif
address
question
perform
mcia
vsv
propag
sever
differ
cell
line
differ
anim
speci
includ
cell
cat
vero
cell
monkey
mdck
cell
dog
mdbk
cell
cattl
cell
pig
shown
figur
purifi
recombin
protein
show
antivir
activ
homolog
anim
cell
cell
heterolog
anim
cell
vero
mdck
mdbk
cell
vitro
antivir
activ
protein
heterolog
anim
cell
significantli
stronger
intercat
ifn
control
although
intercat
ifn
display
high
antivir
activ
vero
cell
significantli
weak
antivir
activ
mdck
mdbk
cell
antivir
activ
cell
furthermor
antivir
activ
better
homolog
heterolog
anim
cell
especi
homolog
anim
cell
origin
cat
howev
antivir
activ
detect
cell
control
group
cell
untreat
ifn
next
want
investig
whether
antivir
activ
recombin
protein
also
broadspectrum
perform
mcia
use
wide
rang
differ
virus
includ
vsv
fcov
cpv
bvdv
pedv
shown
figur
display
vitro
antivir
activ
vsv
fcov
cpv
bvdv
pedv
antivir
activ
especi
strong
fcov
vsv
contrast
antivir
activ
fcov
vsv
significantli
stronger
notabl
differ
observ
cpv
bvdv
pedv
addit
antivir
activ
fcov
vsv
significantli
stronger
intercat
ifn
antivir
activ
cpv
bvdv
pedv
significantli
higher
intercat
ifn
fact
observ
antivir
activ
bvdv
pedv
intercat
ifn
unsurprisingli
antivir
activ
detect
cell
control
group
cell
untreat
ifn
current
cat
continu
becom
common
household
pet
know
wide
varieti
viral
infect
serious
endang
health
pet
cat
felv
fiv
fipv
fcov
felin
caliciviru
fcv
interferon
repres
promis
potenti
therapeut
agent
effect
treat
pet
cat
infect
virus
studi
identifi
two
new
gene
encod
felin
spleen
lymphocyt
cat
follow
sequenc
homolog
analysi
found
share
maximum
nucleotid
sequenc
homolog
maximum
amino
acid
homolog
previous
publish
subtyp
felin
respect
addit
phylogenet
tree
analysi
ifn
cat
speci
construct
use
neighborjoin
analysi
reveal
belong
type
ifn
famili
evolutionari
relationship
known
felin
gene
distant
indic
inde
new
subtyp
felin
deposit
two
gene
genbank
access
number
thu
enrich
data
submit
genbank
studi
characterist
protein
signal
peptid
sequenc
signal
peptid
cleavag
site
phosphoryl
site
glycosyl
site
antigen
epitop
hydrophob
transmembran
region
analyz
use
bioinformat
provid
better
theoret
guidanc
function
studi
protein
matur
protein
normal
biolog
activ
form
signal
peptid
sequenc
remov
precursor
protein
thu
allow
secret
outsid
cell
membran
use
onlin
softwar
predict
signal
peptid
sequenc
protein
consist
amino
acid
residu
signal
peptid
cleavag
site
locat
residu
result
indic
recombin
protein
could
express
vitro
solubl
form
glycosyl
import
posttransl
modif
process
affect
antigen
determin
charg
properti
enzymat
properti
thermal
stabil
protein
similar
previou
report
known
subtyp
observ
nglycosyl
site
present
howev
analys
predict
nine
potenti
oglycosyl
site
six
potenti
oglycosyl
site
differ
previou
report
known
subtyp
studi
shown
glycosyl
site
play
import
role
determin
activ
ifn
exampl
glycosyl
observ
markedli
potent
nonglycosyl
hepat
c
viru
bvdv
yellow
fever
viru
west
nile
viru
even
superior
effect
insectbaculoviru
express
system
one
effect
eukaryot
express
system
prepar
felin
ifn
express
system
capabl
make
posttransl
modif
glycosyl
allow
protein
fold
correctli
thu
produc
highli
activ
stabl
ifn
howev
applic
system
limit
drawback
low
yield
ifn
protein
complic
oper
requir
therefor
e
coli
express
system
still
wide
use
prokaryot
express
system
protein
product
characterist
simpl
procedur
largescal
product
low
cost
gener
recombin
ifn
produc
e
coli
express
system
insolubl
inclus
bodi
form
modifi
fold
correctli
result
loss
biolog
activ
obtain
solubl
biolog
activ
ifn
protein
inclus
bodi
need
denatur
renatur
timeconsum
labori
process
studi
select
prokaryot
solubl
express
system
pcoldtf
prepar
recombin
pcoldtf
system
highli
effici
solubl
express
system
histag
tf
allow
express
protein
effect
modifi
fold
secret
cytoplasm
follow
construct
recombin
e
coli
strain
induct
iptg
protein
express
solubl
form
analyz
via
sdspage
optim
express
condit
protein
purifi
use
histag
affin
column
chromatographi
protein
show
antivir
activ
vsv
microdos
cytopath
effect
inhibit
assay
use
cell
result
provid
basi
studi
develop
therapeut
agent
viral
infect
meanwhil
data
provid
evid
pcoldtf
express
system
use
produc
ifn
full
bioactiv
recombin
felin
first
licens
immunomodul
use
treat
viral
infect
cat
especi
fiv
felv
infect
furthermor
also
exhibit
therapeut
effect
felin
viral
infect
fcv
felin
parvoviru
felin
well
virus
origin
anim
footandmouth
diseas
viru
influenza
viru
bvdv
vsv
prv
rotaviru
studi
result
demonstr
antivir
activ
homolog
anim
cell
cell
cat
heterolog
anim
cell
vero
cell
monkey
mdbk
cell
cattl
mdck
cell
dog
cell
pig
indic
broad
crossspeci
antivir
activ
vitro
similar
previous
publish
find
mdbk
mdck
cell
contrast
antivir
activ
homolog
heterolog
anim
cell
better
intriguingli
protein
exhibit
antivir
activ
mdck
cell
despit
absenc
canin
specul
differ
ifn
differ
physiolog
function
like
respons
differ
result
obtain
studi
compar
publish
studi
furthermor
analysi
broadspectrum
antivir
activ
reveal
effect
vsv
fcov
pedv
bvdv
cpv
five
virus
antivir
activ
strongest
vsv
fcov
signific
differ
antivir
activ
cpv
bvdv
pedv
observ
howev
overal
broadspectrum
antivir
activ
significantli
stronger
recent
combin
antivir
therapi
becom
common
practic
treat
felin
viral
infect
due
pharmacokinet
short
halflif
ifn
alon
mani
publish
studi
focus
combin
therapeut
agent
chemotherapeut
agent
ribavirin
suggest
attract
strategi
use
viral
infect
evalu
antivir
effect
combin
felin
vsv
fcov
cell
result
reveal
vitro
antivir
activ
combin
therapi
significantli
increas
compar
alon
indic
combin
therapi
may
repres
potent
option
monotherapi
treat
viral
infect
cat
howev
hypothesi
requir
explor
vivo
summari
obtain
studi
exhibit
signific
broadspectrum
antivir
activ
homolog
heterolog
cell
vitro
particularli
suggest
promis
candid
develop
effect
therapeut
agent
viral
infect
cat
anim
studi
two
new
subtyp
felin
identifi
character
share
maximum
nucleotid
sequenc
homolog
maximum
amino
acid
homolog
previous
known
subtyp
respect
analyz
characterist
detail
use
bioinformat
follow
solubl
express
optim
induct
condit
e
coli
data
show
purifi
recombin
broadspectrum
antivir
activ
homolog
heterolog
anim
cell
suggest
candid
develop
effect
therapeut
agent
use
viral
infect
pet
cat
research
underway
systemat
evalu
effect
two
novel
feifn
therapeut
agent
cat
viral
infect
vivo
addit
report
sequenc
enrich
ifn
data
submit
genbank
